HsCRP is produced from the liver in case of systemic inflammation and is assumed as by CHF. Alonso-Martinez et al. studied the relationship between NYHA CHF stages and Left Ventricle Ejection Fraction (LVEF) in hospitalized CHF patients. HsCRP levels were found to be reversely correlated to functional capacity and LVEF. Also, higher HsCRP levels were found to predict mortality and rehospitalization a new risk factor for atherosclerosis. Coronary atherosclerosis is manifested (14).